Catalyst Pharmaceuticals Inc (STU:CN2)
€ 20.71 0.15 (0.73%) Market Cap: 2.46 Bil Enterprise Value: 2.04 Bil PE Ratio: 18.19 PB Ratio: 3.87 GF Score: 88/100

Catalyst Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Aug 22, 2023 / 01:00PM GMT
Release Date Price: €13.33 (-0.52%)
Brian Elsbernd
Catalyst Pharmaceuticals, Inc. - Chief Compliance Officer & Chief Legal Officer

Good morning, and welcome to the 2023 Annual Meeting of Stockholders of Catalyst Pharmaceuticals, Inc.

Before we get started, I'd like to go over a few items so you know how to participate in today's meeting. (Operator Instructions) Last, today's meeting is being recorded.

I would now like to introduce Patrick J. McEnany, CEO of Catalyst Pharmaceuticals, who will preside over today's meeting.

Patrick J. McEnany
Catalyst Pharmaceuticals, Inc. - Co-Founder, Chairman, President & CEO

Thanks, Brian. Good morning, and welcome to the 2023 Annual Meeting of Stockholders of Catalyst Pharmaceuticals, Inc. I am Patrick McEnany, the Chairman, President and CEO of the company.

Before the stockholders meeting begins, I want to welcome you and express the thanks of our company's Board of Directors and management for your attendance here today. Our agenda for this meeting calls for your vote on 4 matters. Please hold all questions until the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot